Abstract:Background: The pulmonary surfactant that lines the air-liquid surface within alveoli is a protein-lipid mixture essential for gas exchange. Surfactant lipids and proteins are synthesized and stored in the lamellar body (LB) before being secreted from alveolar type II (AT2) cells. The molecular and cellular mechanisms that regulate these processes are incompletely understood. We previously identified an essential role of general control of amino acid synthesis 5 like 1 (GCN5L1) and the biogenesis of lysosome-related organelle complex 1 subunit 1 (BLOS1) in surfactant system development in zebrafish. Here, we explored the role of GCN5L1 in pulmonary surfactant regulation. Method: GCN5L1 knockout cell lines were generated with the CRISPR/Cas9 system. Cell viability was analyzed by MTT assay. Released surfactant proteins were measured by ELISA. Released surfactant lipids were measured based on coupled enzymatic reactions. Gene overexpression was mediated through lentivirus. The RNA levels were detected through RNA-sequencing (RNA-seq) and quantitative reverse transcription (qRT)- polymerase chain reaction (PCR). The protein levels were detected through western blotting. The cellular localization was analyzed by immunofluorescence. Morphology of the lamellar body was analyzed through transmission electron microscopy (TEM), Lysotracker staining, and BODIPY phosphatidylcholine labeling. Results: Knocking out GCN5L1 in MLE-12 significantly decreased the release of surfactant proteins and lipids. We detected the downregulation of some surfactant-related genes and misregulation of the ROS-Erk-Foxo1-Cebpα axis in mutant cells. Modulating the activity of the axis or reconstructing the mitochondrial expression of GCN5L1 could partially restore the expression of these surfactant-related genes. We further showed that MLE-12 cells contained many LB-like organelles that were lipid enriched and positive for multiple LB markers. These organelles were smaller in size and accumulated in the absence of GCN5L1, indicating both biogenesis and trafficking defects. Accumulated endogenous surfactant protein (SP)-B or exogenously expressed SP-B/SP-C in adenosine triphosphate-binding cassette transporterA3 (ABCA3)-positive organelles was detected in mutant cells. GCN5L1 localized to the mitochondria and LBs. Reconstruction of mitochondrial GCN5L1 expression rescued the organelle morphology but failed to restore the trafficking defect and surfactant release, indicating specific roles associated with different subcellular localizations. Conclusions: In summary, our study identified GCN5L1 as a new regulator of pulmonary surfactant that plays a role in the biogenesis and positioning/trafficking of surfactant-containing LBs.

A dominant negative variant of RAB5B disrupts maturation of surfactant protein B and surfactant protein C

Mutant <i>B3GALT6</i> in a Multiplex Family: A Dominant Variant Co-Segregated With Moderate Malformations

Comprehensive Genetic Variant Discovery in the Surfactant Protein B Gene

Developmental and genetic regulation of human surfactant protein B in vivo.

Surfactant Protein-C Promoter Variants Associated with Neonatal Respiratory Distress Syndrome Reduce Transcription.

Neonatal-onset pulmonary alveolar proteinosis is a phenotype associated with poor outcomes in surfactant protein-C disorder

Hydrophilic But Not Hydrophobic Surfactant Protein Genetic Variants Are Associated With Severe Acute Respiratory Syncytial Virus Infection in Children

A neurodevelopmental disorder associated with a loss-of-function missense mutation in RAB35

Hereditary Mucin Deficiency Caused by Biallelic Loss of Function of <i>MUC5B</i>

Genetic variants of small airways and interstitial pulmonary disease in children

Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation

Population and Disease-Based Prevalence of the Common Mutations Associated With Surfactant Deficiency

GCN5L1 regulates pulmonary surfactant production by modulating lamellar body biogenesis and trafficking in mouse alveolar epithelial cells

Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection

A novel surfactant protein C mutation resulting in aberrant protein processing and altered subcellular localization causes infantile interstitial lung disease

Genetic variant characterization in intron 4 of the surfactant protein B gene.

Surfactant dysfunction disorder masquerading as meconium aspiration syndrome and persistent pulmonary hypertension of the newborn

Rare-variant collapsing analyses identified risk genes for neonatal acute respiratory distress syndrome

Differential Susceptibility of Transgenic Mice Expressing Human Surfactant Protein B Genetic Variants to Pseudomonas Aeruginosa Induced Pneumonia.

Human Surfactant Protein A2 Gene Mutations Impair Dimmer/trimer Assembly Leading to Deficiency in Protein Sialylation and Secretion.

Deficiency in Pulmonary Surfactant Proteins in Mice with Fatty Acid Binding Protein 4-Cre-mediated Knockout of the Tuberous Sclerosis Complex 1 Gene